共 119 条
[1]
Yang J(2012)Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling World J Gastroenterol 18 2938-2947
[2]
Zhang JX(2021)Hepatocellular carcinoma: an overview of the changing landscape of treatment options J Hepatocell Carcinoma 8 387-401
[3]
Wang H(2017)Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis J Carcinog 16 1-752
[4]
Wang GL(2006)Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults J Clin Gastroenterol 40 745-2123
[5]
Hu QG(2007)Significant correlations between severe fatty liver and risk factors for metabolic syndrome J Gastroenterol Hepatol 22 2118-788
[6]
Zheng QC(2010)Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites Hepatology 52 774-117
[7]
Koulouris A(2014)Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team J Hepatol 60 110-873
[8]
Tsagkaris C(2017)New trends on obesity and NAFLD in Asia J Hepatol 67 862-1314
[9]
Spyrou V(2017)The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease Int J Cancer 141 1307-209
[10]
Pappa E(2020)A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement J Hepatol 73 202-919